Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Bone Metastasis in Gastric Cancer Patients

  • Ahn, Jae-Bong (Department of Surgery, Hanyang University College of Medicine) ;
  • Ha, Tae-Kyung (Department of Surgery, Hanyang University College of Medicine) ;
  • Kwon, Sung-Joon (Department of Surgery, Hanyang University College of Medicine)
  • Received : 2010.09.30
  • Accepted : 2010.11.30
  • Published : 2011.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Bone metastasis from stomach cancer occurs only rarely and it is known to have a very poor prognosis. This study examined the clinical characteristics and prognosis of patients who were diagnosed with stomach cancer and bone metastasis. Materials and Methods: The subjects were 19 patients who were diagnosed with stomach cancer at Hanyang University Medical Center from June 1992 to August 2010 and they also had bone metastasis. The survival rate according to many clinicopathologic factors was retrospectively analyzed. Results: 11 patients out of 18 patients (61%) who received an operation were in stage IV and the most common bone metastasis location was the spine. Bone scintigraphy was mostly used for diagnosing bone metastasis and PET-CT and magnetic resonance imaging were used singly or together. The serum alkaline phosphatase at the time of diagnosis had increased in 12 cases and there were clinical symptoms (bone pain) in 16 cases. Treatment was given to 14 cases and it was mostly radiotherapy. There were 2 cases of discovering bone metastasis at the time of diagnosing stomach cancer. The interval after operation to the time of diagnosing bone metastasis for the 18 cases that received a stomach cancer operation was on average $14.9{\pm}17.3$ months and the period until death after the diagnosis of bone metastasis was on average $3.8{\pm}2.6$ months. As a result of univariate survival rate analysis, the group that was treated for bone metastasis had a significantly better survival period when the bone metastasis was singular rather than multiple, as compared to the non-treatment group, yet both factors were not independent prognosis factors on multivariate survival analysis. Conclusions: An examination to confirm the status of bone metastasis when conducting a radio-tracer test after the initial diagnosis and also after an operation is needed for stomach cancer patients, and bone scintigraphy is the most helpfully modality. Making the diagnosis at the early stage and suitable treatments are expected to enhance the survival rate and improve the quality of life even for the patients with bone metastasis.

Keywords

References

  1. Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH. Annual report of the central cancer registry in Korea - 1998 (Based on Registered Data from 124 Hospitals). J Korean Cancer Assoc 2000;32:827-834.
  2. Crivellari D, Carbone A, Sigon R, Buonadonna A, Cannizzaro R, Sorio R, et al. Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature. Tumori 1995;81:74-76.
  3. Noda N, Sano T, Shirao K, Ono H, Katai H, Sasako M, et al. A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. Jpn J Clin Oncol 1996;26:472-475. https://doi.org/10.1093/oxfordjournals.jjco.a023267
  4. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 1950;3:74-85. https://doi.org/10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7
  5. Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori PP, Cavazzini G, et al. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology 1995;52:505-508. https://doi.org/10.1159/000227520
  6. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg 1983;13:173-176. https://doi.org/10.1007/BF02469472
  7. Nishidoi H, Koga S. Clinicopathological study of gastric cancer with bone metastasis. Gan To Kagaku Ryoho 1987;14(5 Pt 2):1717-1722.
  8. Seto M, Tonami N, Koizumi K, Sui O, Hisada K. Bone metastasis in gastric cancer--clinical evaluation of bone scintigrams. Kaku Igaku 1983;20:795-801.
  9. Choi CW, Lee DS, Chung JK, Lee MC, Kim NK, Choi KW, et al. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med 1995;20:310-314. https://doi.org/10.1097/00003072-199504000-00005
  10. Kusumoto H, Haraguchi M, Nozuka Y, Oda Y, Tsuneyoshi M, Iguchi H. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep 2006;16:735-740.
  11. Wilner D. Cancer metastasis to bone. In: Wilner D, ed. Radiology of Bone Tumors and Allied Disorders. Vol 1. Philadelphia: WB Saunders, 1982:3641-3908.
  12. Gold RI, Seeger LL, Bassett LW, Steckel RJ. An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am 1990;28:471-483.
  13. Corcoran RJ, Th rall JH, Kyle RW, Kaminski R, Johnson MC. Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 1976;121:663-667.
  14. Shirazi PH, Rayudu GV, Fordham EW. Review of solitary 18F bone scan lesions. Radiology 1974;112:369-372.
  15. Brown ML. Significance of the solitary lesion in pediatric bone scanning: concise communication. J Nucl Med 1983;24:114-115.
  16. Rappaport AH, Hoff er PB, Genant HK. Unifocal bone findings by scintigraphy. Clinical significance in patients with known primary cancer. West J Med 1978;129:188-192.
  17. Diel IJ, Kaufman M, Bastert G. Metastatic bone disease: fundamental and clinical aspects. 1st ed. Santa Clara: Springer-Verlag Telos, 1994:22-23.
  18. McNeil BJ. Value of bone scanning in neoplastic disease. Semin Nucl Med 1984;14:277-286. https://doi.org/10.1016/S0001-2998(84)80003-3
  19. Murai N, Koga K, Nagamachi S, Nishikawa K, Matsuki K, Kusumoto S, et al. Radiotherapy in bone metastases--with special reference to its effect on relieving pain. Gan No Rinsho 1989;35:1149-1152.
  20. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg 1983;13:173-176. https://doi.org/10.1007/BF02469472
  21. McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev 2000;(2):CD001793.
  22. Yasuda K, Kimura T, Seita M, Takahata T, Akazai Y. A case of gastric cancer accompanied by disseminated carcinomatosis of bone marrow with DIC recovered by sequential therapy consisting of MTX and 5-FU. Gan To Kagaku Ryoho 2008;35:1941-1943.
  23. Migita K, Watanabe A, Sakamoto C, Nakamura T, Ohyama T, Ishikawa H, et al. A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP. Gan To Kagaku Ryoho 2007;34:929-931.
  24. Fujishima Y, Yoneda R, Iwai M, Fukunaga H, Miura M, Koide M, et al. A case of advanced gastric cancer with disseminated carcinomatosis of bone marrow treated by S-1 and CDDP. Gan To Kagaku Ryoho 2009;36:2653-2655.
  25. Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, et al. Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer 2001;91:1191-1200. https://doi.org/10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO;2-0
  26. Carano A, Teitelbaum SL, Konsek JD, Schlesinger PH, Blair HC. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 1990;85:456-461. https://doi.org/10.1172/JCI114459
  27. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995;10:1478-1487.
  28. Chung YS, Choi TY, Ha CY, Kim HM, Lee KJ, Park CH, et al. An unusual case of osteoblastic metastasis from gastric carcinoma. Yonsei Med J 2002;43:377-380.

Cited by

  1. Occipital neuralgia as a presenting symptom of gastric cancer metastasis vol.32, pp.10, 2011, https://doi.org/10.1177/0333102412451362
  2. Isolated ovarian metastasis of gastric cancer: Krukenberg tumor vol.17, pp.6, 2011, https://doi.org/10.5114/wo.2013.37542
  3. Gastric Carcinoma with Bone Marrow Metastasis: A Case Series vol.14, pp.1, 2011, https://doi.org/10.5230/jgc.2014.14.1.54
  4. Pancytopenia and Isolated Bone Marrow Recurrence in a Case of Previously Resected Gastric Carcinoma: A Rare Finding vol.30, pp.s1, 2011, https://doi.org/10.1007/s12288-014-0378-0
  5. Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival vol.14, pp.3, 2014, https://doi.org/10.5230/jgc.2014.14.3.164
  6. False-positive 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) findings of bone metastasis from esophagogastric cancer: report of two cases vol.44, pp.11, 2011, https://doi.org/10.1007/s00595-014-0947-8
  7. A Rare Initial Presentation of Gastric Cancer with Multiple Osteolytic Lesions vol.2015, pp.None, 2011, https://doi.org/10.1155/2015/689431
  8. Targeting mast cells in gastric cancer with special reference to bone metastases vol.21, pp.37, 2015, https://doi.org/10.3748/wjg.v21.i37.10493
  9. Aberrant metastatic behavior and particular features of early gastric cancer vol.123, pp.12, 2011, https://doi.org/10.1111/apm.12469
  10. Upregulation of brain-derived neurotrophic factor in advanced gastric cancer contributes to bone metastatic osteolysis by inducing long pentraxin 3 vol.7, pp.34, 2011, https://doi.org/10.18632/oncotarget.10747
  11. The Flare Phenomenon in a Patient with Advanced Gastric Cancer with Bone Metastases vol.91, pp.3, 2011, https://doi.org/10.3904/kjm.2016.91.3.321
  12. Bone metastasis as the first sign of gastric cancer vol.28, pp.None, 2011, https://doi.org/10.11604/pamj.2017.28.95.13787
  13. Generalized high bone mineral density on bone density scanning: a case of gastric carcinoma with bone metastasis vol.129, pp.2, 2011, https://doi.org/10.1080/00325481.2017.1261607
  14. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis vol.15, pp.None, 2017, https://doi.org/10.1186/s12957-016-1091-2
  15. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER ‐based study vol.7, pp.8, 2011, https://doi.org/10.1002/cam4.1661
  16. Metastatic Gastric cancer: Real world scenario from a developing country vol.7, pp.3, 2018, https://doi.org/10.4103/sajc.sajc_2_18
  17. Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis vol.24, pp.1, 2011, https://doi.org/10.3748/wjg.v24.i1.150
  18. Gastric cancer initially presenting as bone metastasis: Two case reports and a literature review vol.16, pp.5, 2011, https://doi.org/10.3892/ol.2018.9393
  19. 3D Microfluidic Bone Tumor Microenvironment Comprised of Hydroxyapatite/Fibrin Composite vol.7, pp.None, 2019, https://doi.org/10.3389/fbioe.2019.00168
  20. Clinical analysis of bone metastasis of gastric cancer: incidence, clinicopathological features and survival vol.15, pp.19, 2019, https://doi.org/10.2217/fon-2019-0039
  21. Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-019-47533-6
  22. Risk factors and prognosis of bone metastases in newly diagnosed gastric cancer vol.16, pp.12, 2011, https://doi.org/10.2217/fon-2019-0728
  23. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer vol.13, pp.4, 2011, https://doi.org/10.3892/mco.2020.2101
  24. Blood biomarkers of bone metastasis in digestive tract malignant tumors vol.17, pp.12, 2011, https://doi.org/10.2217/fon-2020-0509
  25. Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them vol.10, pp.8, 2011, https://doi.org/10.3390/jcm10081777
  26. Application of artificial intelligence-driven endoscopic screening and diagnosis of gastric cancer vol.27, pp.22, 2011, https://doi.org/10.3748/wjg.v27.i22.2979